Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 4, 2009, Pages 554-559

  Ahmed, Touqeer ^a   Gilani, Anwarul Hassan ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Bisdemethoxycurcumin; Curcumin; Curcuminoids; Memory; Turmeric

Indexed keywords

CHOLINESTERASE INHIBITOR; CURCUMIN; CURCUMIN PLUS BISDEMETHOXYCURCUMIN PLUS DEMETHOXYCURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; PHYSOSTIGMINE; SCOPOLAMINE; TURMERIC; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FRONTAL CORTEX; HIPPOCAMPUS; IC 50; MALE; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMNESIA; ANIMALS; CHOLINESTERASE INHIBITORS; CURCUMA; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; PARASYMPATHOLYTICS; PHYTOTHERAPY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE;

CURCUMA LONGA; RATTUS;

EID: 58349100449     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.09.010     Document Type: Article

References (56)

1. Aggarwal B.B., Kumar A., and Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23 (2003) 363-398
2. Aggarwal B.B., Sundaram C., Malani N., and Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 595 (2007) 1-75
3. Akhondzadeh S., Noroozian M., Mohammadi M., Ohadinia S., Jamshidi A.H., and Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28 (2003) 53-59
4. Ammon H.P., Safayhi H., Mack T., and Sabieraj J. Mechanism of antiinflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 38 (1993) 113-119
5. Baum L., and Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimer's Dis 6 (2004) 367-377 discussion 443-9
6. Baum L., Lam C.W., Cheung S.K., Kwok T., Lui V., Tsoh J., et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28 (2008) 110-113
7. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 (2006) 387-403
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
9. Constantinidis C., Williams G.V., and Goldman-Rakic P.S. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 5 (2002) 175-180
10. Coyle J.T., Price D.L., and DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1983) 1184-1190
11. Dairam A., Limson J.L., Watkins G.M., Antunes E., and Daya S. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem 55 (2007) 1039-1044
12. Dairam A., Fogel R., Daya S., and Limson J.L. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J Agric Food Chem 56 (2008) 3350-3356
13. Daniel S., Limson J.L., Dairam A., Watkins G.M., and Daya S. Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 98 (2004) 266-275
14. Duke J.A. Handbook of phytochemcial constituents of GRAS herbs and other economic plants (1992), CRC Press
15. Duke J.A. Hand book of medicinal herbs. 2nd ed. (2002), CRC Press
16. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223 (2005) 181-190
17. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
18. Eybl V., Kotyzova D., and Koutensky J. Comparative study of natural antioxidants-curcumin, resveratrol and melatonin-in cadmium-induced oxidative damage in mice. Toxicology 225 (2006) 150-156
19. Frautschy S.A., Hu W., Kim P., Miller S.A., Chu T., Harris-White M.E., et al. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22 (2001) 993-1005
20. Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., and Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102 (2007) 1095-1104
21. Gilani A.H., and Rahman A.U. Trends in ethnopharmocology. J Ethnopharmacol 100 (2005) 43-49
22. Gilani A.H., Shah A.J., Ghayur M.N., and Majeed K. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 76 (2005) 3089-3105
23. Giri R.K., Rajagopal V., and Kalra V.K. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91 (2004) 1199-1210
24. Goel A., Kunnumakkara A.B., and Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75 (2008) 787-809
25. Isoma K., Ishikawa M., Ohta M., Ogawa Y., Hasegawa H., Kohda T., et al. Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain. Jpn J Pharmacol 88 (2002) 206-212
26. Kamat A.M., Sethi G., and Aggarwal B.B. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol Cancer Ther 6 (2007) 1022-1030
27. Kapoor L. Handbook of ayurvedic medicinal plants (1990), CRC Press
28. Kim D.S., Park S.Y., and Kim J.K. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 303 (2001) 57-61
29. Kim H., Park B.S., Lee K.G., Choi C.Y., Jang S.S., Kim Y.H., et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 53 (2005) 8537-8541
30. Kunnumakkara A.B., Diagaradjane P., Guha S., Deorukhkar A., Shentu S., Aggarwal B.B., et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to {gamma}-radiation by targeting nuclear factor-{kappa}B-regulated gene products. Clin Cancer Res 14 (2008) 2128-2136
31. Lao C.D., Ruffin M.T.t., Normolle D., Heath D.D., Murray S.I., Bailey J.M., et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6 (2006) 10
32. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., and Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. Jama 278 (1997) 1327-1332
33. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., and Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21 (2001) 8370-8377
34. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11 (1984) 47-60
35. Mukhopadhyay A., Basu N., Ghatak N., and Gujral P.K. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12 (1982) 508-515
36. Nadkarni K. Indian materia medica. Popular Prakashan (1986)
37. Ng T.P., Chiam P.C., Lee T., Chua H.C., Lim L., and Kua E.H. Curry consumption and cognitive function in the elderly. Am J Epidemiol 164 (2006) 898-906
38. NRC. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, D.C.
39. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., and Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 87 (2003) 172-181
40. Ono K., Hasegawa K., Naiki H., and Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochim Biophys Acta 1690 (2004) 193-202
41. Ono K., Hasegawa K., Naiki H., and Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75 (2004) 742-750
42. Ono K., Hamaguchi T., Naiki H., and Yamada M. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease. Biochim Biophys Acta 1762 (2006) 575-586
43. Pan M.H., Huang T.M., and Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27 (1999) 486-494
44. Park S.Y., and Kim D.S. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod 65 (2002) 1227-1231
45. Qin N.Y., Yang F.Q., Wang Y.T., and Li S.P. Quantitative determination of eight components in rhizome (Jianghuang) and tuberous root (Yujin) of Curcuma longa using pressurized liquid extraction and gas chromatography-mass spectrometry. J Pharm Biomed Anal 43 (2007) 486-492
46. Reddy A.C., and Lokesh B.R. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 137 (1994) 1-8
47. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
48. Sreejayan, and Rao M.N. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46 (1994) 1013-1016
49. Sreejayan, and Rao M.N. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49 (1997) 105-107
50. Wahlstrom B., and Blennow G. A study on the fate of curcumin in the rat. Acta Pharm Toxicol (Copenh) 43 (1978) 86-92
51. Wettstein A. Cholinesterase inhibitors and Gingko extracts-are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine 6 (2000) 393-401
52. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
53. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280 (2005) 5892-5901
54. Zhang L., Fiala M., Cashman J., Sayre J., Espinosa A., Mahanian M., et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimer's Dis 10 (2006) 1-7
55. Zhao B.L., Li X.J., He R.G., Cheng S.J., and Xin W.J. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14 (1989) 175-185
56. Zhong P., Gu Z., Wang X., Jiang H., Feng J., and Yan Z. Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease. J Biol Chem 278 (2003) 26888-26896